PharVision Advisers’s Aflac AFL Stock Holding History

PharVision Advisers’s Portfolio AFL Stock Details AFL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,331	Closed	-$367K	–	110
2025 Q4	$367K	Buy	+3,331	New	+$367K	0.19%	155

Other funds holding AFL

JPH

Japan Post Holdings Tokyo, Japan $5.97B AUM 11.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PharVision Advisers's AFL Position: Q1 2026 in Review

PharVision Advisers sold out of Aflac (AFL) in Q1 2026, closing a stake of 3,331 shares — an estimated $367K sold.

PharVision Advisers first reported a position in AFL in Q4 2025 and held it in 1 quarter. The position peaked at $367K in Q4 2025. 1,653 funds tracked by Wall St. Rank hold AFL as of Q1 2026.

PharVision Advisers reported no remaining Aflac position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 3,331 Aflac shares in Q1 2026, an estimated $367K.
PharVision Advisers first reported a position in Aflac in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Aflac position peaked at $367K in Q4 2025.
1,653 funds tracked by Wall St. Rank held Aflac as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.